Achmea Investment Management B.V. Horizon Therapeutics Public LTD CO Transaction History

Achmea Investment Management B.V.

  • $5.25 Billion
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 09, 2023
SELL
$62.39 - $113.8 $745,248 - $1.36 Million
-11,945 Reduced 96.7%
407 $43,000
Q1 2022

May 16, 2022
SELL
$86.42 - $109.81 $634,841 - $806,664
-7,346 Reduced 37.29%
12,352 $1.3 Million
Q3 2021

Nov 12, 2021
BUY
$91.91 - $110.37 $37,407 - $44,920
407 Added 2.11%
19,698 $2.16 Million
Q4 2020

Feb 22, 2021
BUY
$67.0 - $84.39 $1.29 Million - $1.63 Million
19,291 New
19,291 $1.41 Million

Others Institutions Holding HZNP

# of Institutions
39
Shares Held
2.07M
Call Options Held
0
Put Options Held
20K
View Full List

About Horizon Therapeutics Public Ltd Co

HZNP Quotes by TradingView
  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Achmea Investment Management B.V. Portfolio

Follow Achmea Investment Management B.V. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Achmea Investment Management B.V., based on Form 13F filings with the SEC.

News

Stay updated on Achmea Investment Management B.V. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email